Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected3M Return
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | MRNA | PFE | BACK |
|---|---|---|---|
| Return | |||
| Last Price | 146.05 | 28.50 | 0.13 |
| Daily Change | − 1.89% | − 1.09% | — |
| Period ReturnPast 3 Months | + 217.64% | + 11.22% | — |
| Valuation | |||
| Market Cap | $58.0 B | $162 B | $1.89 K |
| P/E Ratio | — | — | — |
| Dividend Yield | — | — | — |
| Net MarginTrailing 12M | 141.4% | — | 23,232.4% |
| Risk | |||
| Beta | 1.22 | — | -1.12 |
| 52-Week Range | 22.28 — $176.66 | — | 0.00 — $0.21 |
| Company | |||
| Sector | Health Care | Health Care | — |
| Industry | Biotechnology | Pharmaceuticals | Biotechnology |
Company
- MRNAHealth Care · Biotechnology
- PFEHealth Care · Pharmaceuticals
- BACKBiotechnology
Metrics could not be loaded for PFE: P/E, dividend, beta and the 52-week range stay empty in that column.
Alpaca · SIPUpdated 21:5915 Minutes Delayed
To Understand This